PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Recombinant Human MMP-8 (carrier-free), 100 µg
Recombinant Human MMP-8 (carrier-free), 25 µg
Recombinant Human MMP-9 (carrier-free), 10 μg
Recombinant Human MMP-9 (carrier-free), 100 μg
Recombinant Human MMP-9 (carrier-free), 25 μg
Recombinant Human MMP-9 (dimer, carrier-free), 10 μg
Recombinant Human MMP-9 (dimer, carrier-free), 100 μg
Recombinant Human MMP-9 (dimer, carrier-free), 25 μg
Recombinant Human Neurturin (carrier-free), 20 µg
Recombinant Human Neurturin (carrier-free), 5 µg
Recombinant Human NGAL (Lipocalin-2) (carrier-free), 10 μg
Recombinant Human NGAL (Lipocalin-2) (carrier-free), 100 μg
Recombinant Human NGAL (Lipocalin-2) (carrier-free), 25 μg
Recombinant Human NGAL (Lipocalin-2) (carrier-free), 500 μg
Recombinant Human NGAL (Lipocalin-2) (ELISA Std.), 4 pack
Recombinant Human NGFR (TNFRSF16)-Fc Chimera (carrier-free), 10 μg